Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.
about
Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer.Effects of different preprocessing algorithms on the prognostic value of breast tumour microscopic images.bFGF in tumor tissue independently prognosticates disease outcome of a natural course of invasive breast cancer.The Notch Pathway in Breast Cancer Progression
P2860
Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Do Patients with Luminal A Bre ...... trospective Multicenter Study.
@ast
Do Patients with Luminal A Bre ...... trospective Multicenter Study.
@en
type
label
Do Patients with Luminal A Bre ...... trospective Multicenter Study.
@ast
Do Patients with Luminal A Bre ...... trospective Multicenter Study.
@en
prefLabel
Do Patients with Luminal A Bre ...... trospective Multicenter Study.
@ast
Do Patients with Luminal A Bre ...... trospective Multicenter Study.
@en
P2093
P2860
P1433
P1476
Do Patients with Luminal A Bre ...... trospective Multicenter Study.
@en
P2093
Achim Wöckel
Catharina Bartmann
Joachim Diessner
Lukas Schwentner
Manfred Wischnewsky
Roland Stein
Rolf Kreienberg
Sebastian Häusler
Tanja Stüber
Wolfgang Janni
P2860
P304
P356
10.1371/JOURNAL.PONE.0168730
P407
P577
2016-12-19T00:00:00Z